Skip to content

Earnings yield at other companies

Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
AbbVie logo
AbbVieABBV
0.9%-0.2pp
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
-5.9%-2.7pp
Establishment Labs logo
Establishment LabsESTA
-2.6%-1.0pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
-5.9%-2.7pp

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$317.46M+7.8%
Enterprise value$371.78M+0.1%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s earnings yield?
AirSculpt Technologies, Inc. (AIRS) reported earnings yield of -3.5% in Q3 2025.
How has AirSculpt Technologies, Inc.'s earnings yield changed year-over-year?
AirSculpt Technologies, Inc.'s earnings yield decreased by 37.1% year-over-year, from -2.6% to -3.5%.
What is the long-term trend for AirSculpt Technologies, Inc.'s earnings yield?
Over 3 years (2021 to 2024), AirSculpt Technologies, Inc.'s earnings yield has grown at a -10.5% compound annual growth rate (CAGR), from 3.7% to -2.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.